<DOC>
	<DOCNO>NCT01182142</DOCNO>
	<brief_summary>Capecitabine orally-administered chemotherapeutic agent use treatment metastatic breast colorectal cancer . The role capecitabine treatment metastatic renal cell carcinoma discuss . In trial , evaluate efficacy capecitabine metastatic renal cell carcinoma patient .</brief_summary>
	<brief_title>Study Capecitabine Metastatic Non-clear Cell Renal Cell Carcinoma ( RCC ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>histologically confirm nonclear cell renal cell carcinoma confirm metastatic site chemotherapy history metastasis CNS previous target therapy tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>